Halodex Dermal Cream contains Halobetasol 0.05% w/w, a potent topical corticosteroid indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis, eczema, and dermatitis. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing erythema, swelling, and itching. Halodex Dermal Cream is intended for short-term use due to the risk of systemic absorption and potential adverse effects associated with prolonged corticosteroid therapy. It should be applied sparingly to the affected area once or twice daily as directed by a healthcare professional, ensuring avoidance of sensitive areas such as the face, groin, and axillae unless specifically prescribed. Patients should be advised to use the minimal effective amount and duration to mitigate risks such as skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal (HPA) axis suppression. Contraindications include hypersensitivity to halobetasol or any cream excipients, untreated bacterial, viral, or fungal skin infections, and use in pediatric patients without medical supervision. Halodex Dermal Cream should be stored at room temperature, protected from light and moisture. Consultation with a healthcare provider is recommended prior to initiation to ensure appropriate diagnosis and monitoring.